Lurbinectedin as second-line treatment for patients with small-cell lung cancer: a single-arm, open-label, phase 2 basket trial

Trigo, J; Subbiah, V; Besse, B; Moreno, V; Lopez, R; Sala, MA; Peters, S; Ponce, S; Fernandez, C; Alfaro, V; Gomez, J; Kahatt, C; Zeaiter, A; Zaman, K; Boni, V; Arrondeau, J; Martinez, M; Delord, JP; Awada, A; Kristeleit, R; Olmedo, ME; Wannesson, L; Valdivia, J; Rubio, MJ; Anton, A; Sarantopoulos, J; Chawla, SP; Mosquera-Martinez, J; D’Arcangelo, M; Santoro, A; Villalobos, VM; Sands, J; Paz-Ares, L – 2020